STAT News

STAT+: FDA approves novel Bayer drug to reduce recurrence of stroke

Bayer's drug is the first in a novel class of medications designed to prevent blood clots without increasing risk of bleeding.

By STAT News

1 min read
STAT+: FDA approves novel Bayer drug to reduce recurrence of stroke
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights